Bayer S R, Seibel M M, Saffan D S, Berger M J, Taymor M L
Department of Obstetrics and Gynecology, Beth Israel Hospital, Harvard Medical School, Boston MA 02215.
J Reprod Med. 1988 Feb;33(2):179-83.
We compared pregnancy rates between a danazol-treated and an untreated group of infertile women with minimal endometriosis. After completion of a basic infertility workup and laparoscopy, women with minimal endometriosis were entered into the study and randomly selected to receive either a six-month course of danazol or no treatment at all. Those patients with other infertility factors were included in the study only if the factors were correctable and ultimately determined to be noncontributory. Life-table analysis was used to compare pregnancy rates between the two groups over a 12-month period that started immediately after laparoscopy in the untreated group and after completion of danazol therapy in the treated group. The cumulative pregnancy rate (+/- SEM) was 37.2 +/- 8.4% in the danazol group (n = 37) and 57.4 +/- 10.4% in the untreated group (n = 36) (NS, P greater than .10). This prospective, randomized study showed danazol to be ineffective in improving pregnancy rates over doing nothing at all in patients with minimal endometriosis.
我们比较了经达那唑治疗的轻度子宫内膜异位症不孕女性组与未治疗组之间的妊娠率。在完成基本的不孕检查和腹腔镜检查后,轻度子宫内膜异位症女性进入研究,并随机选择接受为期六个月的达那唑疗程或完全不接受治疗。只有当其他不孕因素可纠正且最终确定为非促成因素时,患有这些因素的患者才被纳入研究。采用寿命表分析来比较两组在12个月期间的妊娠率,未治疗组在腹腔镜检查后立即开始计算,治疗组在达那唑治疗完成后开始计算。达那唑组(n = 37)的累积妊娠率(±标准误)为37.2 ± 8.4%,未治疗组(n = 36)为57.4 ± 10.4%(无显著性差异,P大于0.10)。这项前瞻性随机研究表明,对于轻度子宫内膜异位症患者,达那唑在提高妊娠率方面并不比完全不治疗更有效。